{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:40:13Z","timestamp":1759848013872,"version":"build-2065373602"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J011060","2022J011060","2022J011060"],"award-info":[{"award-number":["2022J011060","2022J011060","2022J011060"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"High-level Talent Training Program of Fujian Cancer Hospital","award":["2024YNG08","2024YNG08","2024YNG08"],"award-info":[{"award-number":["2024YNG08","2024YNG08","2024YNG08"]}]},{"name":"IIT Funds of Fujian Cancer Hospital","award":["202413002","202413002","202413002"],"award-info":[{"award-number":["202413002","202413002","202413002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18988-7","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:59:53Z","timestamp":1759845593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modified RECIST submodels and ordinal regression model predict neoadjuvant chemoimmunotherapy response in locally advanced gastric cancer\u200b\u200b"],"prefix":"10.1038","volume":"15","author":[{"given":"Shu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaisheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"18988_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2478\/raon-2024-0028","volume":"58","author":"J Drnovsek","year":"2024","unstructured":"Drnovsek, J., Homan, M., Zidar, N. & Smid, L. M. Pathogenesis and potential reversibility of intestinal metaplasia - a milestone in gastric carcinogenesis. Radiol. Oncol. 58, 186\u2013195. https:\/\/doi.org\/10.2478\/raon-2024-0028 (2024).","journal-title":"Radiol. Oncol."},{"key":"18988_CR2","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3390\/tomography8030098","volume":"8","author":"F Crimi","year":"2022","unstructured":"Crimi, F. et al. Predictors of metastatic lymph nodes at preoperative staging CT in gastric adenocarcinoma. Tomography 8, 1196\u20131207. https:\/\/doi.org\/10.3390\/tomography8030098 (2022).","journal-title":"Tomography"},{"key":"18988_CR3","doi-asserted-by":"publisher","first-page":"11014","DOI":"10.7189\/jogh.12.11014","volume":"12","author":"H Li","year":"2022","unstructured":"Li, H. et al. Survival of gastric cancer in China from 2000 to 2022: A nationwide systematic review of hospital-based studies. J. Glob Health. 12, 11014. https:\/\/doi.org\/10.7189\/jogh.12.11014 (2022).","journal-title":"J. Glob Health"},{"key":"18988_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12957-023-03221-4","volume":"21","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. Laparoscopic versus open gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: a comprehensive contrastive analysis with propensity score matching. World J. Surg. Oncol. 21, 350. https:\/\/doi.org\/10.1186\/s12957-023-03221-4 (2023).","journal-title":"World J. Surg. Oncol."},{"key":"18988_CR5","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran, S. E. et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet 393, 1948\u20131957. https:\/\/doi.org\/10.1016\/S0140-6736(18)32557-1 (2019).","journal-title":"Lancet"},{"key":"18988_CR6","doi-asserted-by":"publisher","first-page":"1214599","DOI":"10.3389\/fonc.2023.1214599","volume":"13","author":"W Lin","year":"2023","unstructured":"Lin, W., Huang, Z., Du, Z., Wang, Y. & Zuo, T. Case report: clinical application of continuous arterial infusion chemotherapy in neoadjuvant therapy for locally advanced gastric cancer. Front. Oncol. 13, 1214599. https:\/\/doi.org\/10.3389\/fonc.2023.1214599 (2023).","journal-title":"Front. Oncol."},{"key":"18988_CR7","doi-asserted-by":"publisher","first-page":"1077675","DOI":"10.3389\/fonc.2023.1077675","volume":"13","author":"BW Liu","year":"2023","unstructured":"Liu, B. W., Shang, Q. X., Yang, Y. S. & Chen, L. Q. Efficacy and safety of PD-1\/PD-L1 inhibitor combined with chemotherapy versus chemotherapy alone in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis. Front. Oncol. 13, 1077675. https:\/\/doi.org\/10.3389\/fonc.2023.1077675 (2023).","journal-title":"Front. Oncol."},{"key":"18988_CR8","doi-asserted-by":"crossref","unstructured":"Miller, A. B., Hoogstraten, B., Staquet, M. & Winkler, A. Reporting results of cancer treatment. Cancer 47, 207-14(1981).","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6"},{"key":"18988_CR9","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer. 45, 0\u2013247 (2009).","journal-title":"Eur. J. Cancer"},{"key":"18988_CR10","doi-asserted-by":"crossref","unstructured":"Chun, J. W. et al. Non-sentinel node metastasis prediction during surgery in breast cancer patients with one to three positive Sentinel node(s) following neoadjuvant chemotherapy. Scientific Reports 13\u200b\u200b, 4480 (2023).","DOI":"10.1038\/s41598-023-31628-2"},{"key":"18988_CR11","doi-asserted-by":"crossref","unstructured":"Yu, Q., Zhang, H. & Song, J. S. Junkang. Dissociated response to PD-1 inhibitors combined with radiotherapy in patients with advanced metastatic solid tumors: a single-center experience. World J. Surg. Oncology 21, 228 (2023).","DOI":"10.1186\/s12957-023-03122-6"},{"issue":"3","key":"18988_CR12","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/S1470-2045(22)00742-2","volume":"24","author":"L Shankar","year":"2023","unstructured":"Shankar, L. et al. Harnessing imaging tools to guide immunotherapy trials: summary from the National cancer Institute cancer imaging steering committee workshop. Lancet Oncol. 24 (3), e133\u2013e143 (2023).","journal-title":"Lancet Oncol."},{"key":"18988_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/jgo-23-167","volume":"14","author":"KL Yin","year":"2023","unstructured":"Yin, K. L. et al. The combination of a prolonged treatment time window and alpha-fetoprotein benefits the tumor response of hepatocellular carcinoma patients as evaluated by the imrecist: a single-center, retrospective study. J. Gastrointest. Oncol. 14, 11 (2023).","journal-title":"J. Gastrointest. Oncol."},{"key":"18988_CR14","doi-asserted-by":"publisher","first-page":"e23815","DOI":"10.1097\/MD.0000000000023815","volume":"99","author":"S Park","year":"2020","unstructured":"Park, S., Lee, Y., Kim, T. S., Kim, S. K. & Han, J. Y. Response evaluation after immunotherapy in NSCLC: early response assessment using FDG PET\/CT. Medicine 99, e23815 (2020).","journal-title":"Medicine"},{"key":"18988_CR15","doi-asserted-by":"publisher","first-page":"1193174","DOI":"10.3389\/fonc.2023.1193174","volume":"13","author":"A Annovazzi","year":"2023","unstructured":"Annovazzi, A. et al. Prognostic value of [18F]-FDG PET\/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors. Front. Oncol. 13, 1193174. https:\/\/doi.org\/10.3389\/fonc.2023.1193174 (2023).","journal-title":"Front. Oncol."},{"key":"18988_CR16","doi-asserted-by":"crossref","unstructured":"Stewart et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Archives Pathol. & Lab. Medicine133\u200b\u200b, 1359-1360 (2009).","DOI":"10.5858\/133.9.1359"},{"key":"18988_CR17","doi-asserted-by":"crossref","unstructured":"Frederico, S. C. et al. Neoadjuvant immune checkpoint Inhibition in the management of glioblastoma: exploring a new frontier. Frontiers Immunology 14\u200b\u200b, 1057567 (2023).","DOI":"10.3389\/fimmu.2023.1057567"},{"key":"18988_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41467-023-44186-y","volume":"15","author":"JX Lin","year":"2024","unstructured":"Lin, J. X. et al. Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial. Nat. Commun. 15, 12 (2024).","journal-title":"Nat. Commun."},{"key":"18988_CR19","first-page":"14","volume":"110","author":"N Li","year":"2024","unstructured":"Li, N. et al. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study. Int. J. Surg. 110, 14 (2024).","journal-title":"Int. J. Surg."},{"key":"18988_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00330-014-3373-9","volume":"25","author":"T Saito","year":"2015","unstructured":"Saito, T. et al. Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer. Eur. Radiol. 25, 368\u2013374 (2015).","journal-title":"Eur. Radiol."},{"key":"18988_CR21","doi-asserted-by":"publisher","first-page":"101348","DOI":"10.1016\/j.eclinm.2022.101348","volume":"46","author":"Y Cui","year":"2022","unstructured":"Cui, Y. et al. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study. EClinicalMedicine 46, 101348. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101348 (2022).","journal-title":"EClinicalMedicine"},{"key":"18988_CR22","first-page":"225","volume":"17","author":"Z Zhou","year":"2014","unstructured":"Zhou, Z., He, J., Liu, S., Guan, W. & Zhou, Z. [Diagnostic value of magnetic resonance diffusion weighted imaging for metastatic lymph nodes in patients with gastric cancer]. Zhonghua Wei Chang. Wai Ke Za zhi = Chin. J. Gastrointest. Surg. 17, 225 (2014).","journal-title":"Zhonghua Wei Chang. Wai Ke Za zhi = Chin. J. Gastrointest. Surg."},{"key":"18988_CR23","first-page":"10","volume":"31","author":"H Bai","year":"2019","unstructured":"Bai, H. et al. Predictive values of multidetector-row computed tomography combined with serum tumor biomarkers in preoperative lymph node metastasis of gastric cancer. \u4e2d\u56fd\u764c\u75c7\u7814\u7a76: \u82f1\u6587\u7248. 31, 10 (2019).","journal-title":"\u4e2d\u56fd\u764c\u75c7\u7814\u7a76: \u82f1\u6587\u7248"},{"key":"18988_CR24","first-page":"309","volume":"20","author":"Y Chai","year":"2017","unstructured":"Chai, Y. et al. [Preoperative assessment value of spectral CT quantitative parameters in lymph node metastasis of gastric cancer]. Zhonghua Wei Chang. Wai Ke Za zhi = Chin. J. Gastrointest. Surg. 20, 309 (2017).","journal-title":"Zhonghua Wei Chang. Wai Ke Za zhi = Chin. J. Gastrointest. Surg."},{"key":"18988_CR25","doi-asserted-by":"crossref","unstructured":"Saddiq, A. A. et al. Antigenotoxicity, and characterization of Calotropis procera and its Rhizosphere-Inhabiting actinobacteria: in vitro and in vivo studies. Molecules 27, 3123 (2022).","DOI":"10.3390\/molecules27103123"},{"key":"18988_CR26","doi-asserted-by":"publisher","first-page":"100813","DOI":"10.1016\/j.lana.2024.100813","volume":"36","author":"AH Hebert","year":"2024","unstructured":"Hebert, A. H. & Hill, A. L. Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019 to 2022. Lancet Reg. Health Am. 36, 100813. https:\/\/doi.org\/10.1016\/j.lana.2024.100813 (2024).","journal-title":"Lancet Reg. Health Am."},{"key":"18988_CR27","doi-asserted-by":"crossref","unstructured":"Koerner, A. S., Moy, R. H., Ryeom, S. W. & Yoon, S. S. The present and future of neoadjuvant and adjuvant therapy for locally advanced gastric cancer. Cancers 15\u200b\u200b, 4114 (2023).","DOI":"10.3390\/cancers15164114"},{"key":"18988_CR28","first-page":"37","volume":"12","author":"XZ Wang","year":"2020","unstructured":"Wang, X. Z. et al. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines. \u4e16\u754c\u80c3\u80a0\u80bf\u7624\u5b66\u6742\u5fd7: \u82f1\u6587\u7248(\u7535\u5b50\u7248). 12, 37\u201353 (2020).","journal-title":"\u4e16\u754c\u80c3\u80a0\u80bf\u7624\u5b66\u6742\u5fd7: \u82f1\u6587\u7248(\u7535\u5b50\u7248)"},{"key":"18988_CR29","unstructured":"Kang, Y. K., Yook, J. H., Park, Y. K., Lee, J. S. & Noh, S. H. PRODIGY: A phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer. Journal Clin. Oncology 39\u200b\u200b, 2903-2913 (2021)."},{"key":"18988_CR30","doi-asserted-by":"crossref","unstructured":"Cao, X. et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma: a cost-effectiveness analysis. Therapeutic Adv. Med. Oncology 15\u200b\u200b, 17588359231171038 (2023).","DOI":"10.1177\/17588359231171038"},{"key":"18988_CR31","doi-asserted-by":"crossref","unstructured":"Wei, J. et al. Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial. Nature Communications 14\u200b\u200b, 4904 (2023).","DOI":"10.1038\/s41467-023-40480-x"},{"key":"18988_CR32","first-page":"857","volume":"40","author":"CX Yan","year":"2018","unstructured":"Yan, C. X. et al. Value of double contrast-enhanced ultrasound QontraXt three-dimensional pseudocolor quantitative analysis to therapeutic effect evaluation of preoperative neoadjuvant chemotherapy in advanced gastric cancer patients. Zhonghua Zhong Liu Za Zhi [Chinese J. Oncology]. 40, 857\u2013863 (2018).","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese J. Oncology]"},{"key":"18988_CR33","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3760\/cma.j.cn112139-20200114-00027","volume":"58","author":"YK Wang","year":"2020","unstructured":"Wang, Y. K. et al. Accuracy comparision of abdominal enhanced CT and endoscopic ultrasound in the staging of gastric cancer after neoadjuvant chemotherapy: a post hoc analysis of a randomized clinical trial]. Zhonghua Wai Ke Za Zhi. 58, 614\u2013618. https:\/\/doi.org\/10.3760\/cma.j.cn112139-20200114-00027 (2020).","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"18988_CR34","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/jmri.25391","volume":"45","author":"Q Yuan","year":"2017","unstructured":"Yuan, Q. et al. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients. J. Magn. Reson. Imaging. 45, 908\u2013916. https:\/\/doi.org\/10.1002\/jmri.25391 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"key":"18988_CR35","doi-asserted-by":"publisher","first-page":"109793","DOI":"10.1016\/j.radonc.2023.109793","volume":"186","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Cancer immunotherapy response prediction from multi-modal clinical and image data using semi-supervised deep learning. Radiother Oncol. 186, 109793. https:\/\/doi.org\/10.1016\/j.radonc.2023.109793 (2023).","journal-title":"Radiother Oncol."},{"key":"18988_CR36","doi-asserted-by":"publisher","unstructured":"Zurlo, I. V. et al. Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren\u2019s Classification in Pan-Cancer Analysis Era? Cancers (Basel). 12 https:\/\/doi.org\/10.3390\/cancers12071749 (2020).","DOI":"10.3390\/cancers12071749"},{"key":"18988_CR37","doi-asserted-by":"publisher","first-page":"e38376","DOI":"10.1097\/md.0000000000038376","volume":"103","author":"C Liu","year":"2024","unstructured":"Liu, C., Lu, J. & An, L. Development and validation of nomograms for predicting the prognosis of early and late recurrence of advanced gastric cancer after radical surgery based on post-recurrence survival. Med. (Baltim). 103, e38376. https:\/\/doi.org\/10.1097\/md.0000000000038376 (2024).","journal-title":"Med. (Baltim)."},{"key":"18988_CR38","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/sla.0000000000003370","volume":"273","author":"G Jomrich","year":"2021","unstructured":"Jomrich, G. et al. High systemic Immune-Inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma. Ann. Surg. 273, 532\u2013541. https:\/\/doi.org\/10.1097\/sla.0000000000003370 (2021).","journal-title":"Ann. Surg."},{"key":"18988_CR39","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41430-022-01120-7","volume":"76","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y. et al. Association among prognostic nutritional index, post-operative infection and prognosis of stage II\/III gastric cancer patients following radical gastrectomy. Eur. J. Clin. Nutr. 76, 1449\u20131456. https:\/\/doi.org\/10.1038\/s41430-022-01120-7 (2022).","journal-title":"Eur. J. Clin. Nutr."},{"key":"18988_CR40","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s12029-023-00937-0","volume":"54","author":"S Karra","year":"2023","unstructured":"Karra, S. et al. Diagnostic utility of NLR, PLR and MLR in early diagnosis of gastric cancer: an analytical Cross-Sectional study. J. Gastrointest. Cancer. 54, 1322\u20131330. https:\/\/doi.org\/10.1007\/s12029-023-00937-0 (2023).","journal-title":"J. Gastrointest. Cancer"},{"key":"18988_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00262-021-02960-1","volume":"71","author":"IV Zurlo","year":"2022","unstructured":"Zurlo, I. V. et al. Predictive value of NLR, TILs (CD4+\/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer. Cancer Immunol. Immunother. 71, 45\u201355. https:\/\/doi.org\/10.1007\/s00262-021-02960-1 (2022).","journal-title":"Cancer Immunol. Immunother"},{"key":"18988_CR42","doi-asserted-by":"publisher","first-page":"e35585","DOI":"10.1097\/md.0000000000035585","volume":"102","author":"C Liu","year":"2023","unstructured":"Liu, C., Tao, F., Lu, J., Park, S. & An, L. Defining nomograms for predicting prognosis of early and late recurrence in gastric cancer patients after radical gastrectomy. Med. (Baltim). 102, e35585. https:\/\/doi.org\/10.1097\/md.0000000000035585 (2023).","journal-title":"Med. (Baltim)."},{"key":"18988_CR43","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ijrobp.2004.11.017","volume":"62","author":"FM Vecchio","year":"2005","unstructured":"Vecchio, F. M. et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 62, 752\u2013760. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.11.017 (2005).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"18988_CR44","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1097\/ms9.0000000000000765","volume":"85","author":"L Fan","year":"2023","unstructured":"Fan, L. et al. First-line treatment options for advanced gastric\/gastroesophageal junction cancer patients with PD-L1-positive: a systematic review and meta-analysis. Ann. Med. Surg. (Lond). 85, 2875\u20132883. https:\/\/doi.org\/10.1097\/ms9.0000000000000765 (2023).","journal-title":"Ann. Med. Surg. (Lond)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18988-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18988-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18988-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:59:59Z","timestamp":1759845599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18988-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18988"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18988-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and authorized by the Fujian Cancer Hospital ethics committee (Ethical approval number: K2023-066-01; ChiECRCT20210434). Before participating in the trial, all patients signed informed consent documents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"34942"}}